Literature DB >> 22977356

Cell targeting in anti-cancer gene therapy.

Mohd Azmi Mohd Lila1, John Shia Kwong Siew, Hayati Zakaria, Suria Mohd Saad, Lim Shen Ni, Jafri Malin Abdullah.   

Abstract

Gene therapy is a promising approach towards cancer treatment. The main aim of the therapy is to destroy cancer cells, usually by apoptotic mechanisms, and preserving others. However, its application has been hindered by many factors including poor cellular uptake, non-specific cell targeting and undesirable interferences with other genes or gene products. A variety of strategies exist to improve cellular uptake efficiency of gene-based therapies. This paper highlights advancements in gene therapy research and its application in relation to anti-cancer treatment.

Entities:  

Keywords:  Gene therapy; anti-cancer; apoptosis; cell targeting

Year:  2004        PMID: 22977356      PMCID: PMC3438147     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  119 in total

1.  The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.

Authors:  C Kitson; B Angel; D Judd; S Rothery; N J Severs; A Dewar; L Huang; S C Wadsworth; S H Cheng; D M Geddes; E W Alton
Journal:  Gene Ther       Date:  1999-04       Impact factor: 5.250

2.  Effects of membrane-active agents in gene delivery.

Authors:  E Wagner
Journal:  J Control Release       Date:  1998-04-30       Impact factor: 9.776

3.  A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia.

Authors:  A Fasbender; J Zabner; B G Zeiher; M J Welsh
Journal:  Gene Ther       Date:  1997-11       Impact factor: 5.250

Review 4.  Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).

Authors:  M J Hope; B Mui; S Ansell; Q F Ahkong
Journal:  Mol Membr Biol       Date:  1998 Jan-Mar       Impact factor: 2.857

5.  Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice.

Authors:  R O Snyder; S K Spratt; C Lagarde; D Bohl; B Kaspar; B Sloan; L K Cohen; O Danos
Journal:  Hum Gene Ther       Date:  1997-11-01       Impact factor: 5.695

6.  Pharmacologic control of a humanized gene therapy system implanted into nude mice.

Authors:  S R Magari; V M Rivera; J D Iuliucci; M Gilman; F Cerasoli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection.

Authors:  S Li; W C Tseng; D B Stolz; S P Wu; S C Watkins; L Huang
Journal:  Gene Ther       Date:  1999-04       Impact factor: 5.250

8.  Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes.

Authors:  L G Barron; K B Meyer; F C Szoka
Journal:  Hum Gene Ther       Date:  1998-02-10       Impact factor: 5.695

9.  Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance.

Authors:  H Kagami; J C Atkinson; S M Michalek; B Handelman; S Yu; B J Baum; B O'Connell
Journal:  Hum Gene Ther       Date:  1998-02-10       Impact factor: 5.695

10.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.